Showing results (191-200 of 6,006) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|January 30, 2004
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridinesChafiq Hamdouchi, Heather Keyser, Elizabeth Collins, et al.
Molecular Cancer Therapeutics|January 30, 2004
Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytesMaria Nunes, Celine Shi, Lee M Greenberger
Molecular Cancer Therapeutics|January 30, 2004
Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acidTakashi Ikeda, Yukiko Nakata, Fumihiko Kimura, et al.
Molecular Cancer Therapeutics|January 30, 2004
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosisAli R Jazirehi, Benjamin Bonavida
Molecular Cancer Therapeutics|October 28, 2003
A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: synthesis, in vitro cytotoxicity, and pilot in vivo 19F magnetic resonance spectraWilliam M Spees, Guangli Yang, Darren Veach, et al.
Molecular Cancer Therapeutics|October 28, 2003
Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: directed apoptotic events in vascular endothelial cellsYuying Liu, Lawrence H Cheung, Philip Thorpe, et al.
Molecular Cancer Therapeutics|October 28, 2003
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone BLianne Fuino, Purva Bali, Sylvie Wittmann, et al.
Molecular Cancer Therapeutics|October 28, 2003
Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitroNatalya M Khazenzon, Alexander V Ljubimov, Alexander J Lakhter, et al.
Molecular Cancer Therapeutics|October 28, 2003
Carcinoembryonic antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal cancer therapyYuanhao Li, Yu Chen, Jeanette Dilley, et al.
Molecular Cancer Therapeutics|October 28, 2003
Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancerTinya J Abrams, Lesley J Murray, Enrico Pesenti, et al.
Pageof 601